Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial

OBJECTIVE: To evaluate the safety, efficacy, pharmacokinetics, immunogenicity, and radiographic progression through 2 years of treatment with intravenous (IV) golimumab plus methotrexate (MTX) in an open‐label extension of a phase III trial of patients with active rheumatoid arthritis (RA) despite M...

Descripción completa

Detalles Bibliográficos
Autores principales: Bingham, Clifton O., Mendelsohn, Alan M., Kim, Lilianne, Xu, Zhenhua, Leu, Jocelyn, Han, Chenglong, Lo, Kim Hung, Westhovens, Rene, Weinblatt, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063174/
https://www.ncbi.nlm.nih.gov/pubmed/25623393
http://dx.doi.org/10.1002/acr.22556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063174/
https://www.ncbi.nlm.nih.gov/pubmed/25623393
http://dx.doi.org/10.1002/acr.22556

Ejemplares similares